Quris AI

Quris AI is an Israeli healthtech company developing technology to predict human drug responses prior to clinical trial stages. Detailed public information on founders, founding year, employee count, funding rounds, or named customers is not something I can confirm with sufficient confidence to cite.

The company is building a platform that combines synthetic biology and artificial intelligence to simulate the human body's response to drug compounds, with the goal of reducing the high failure rates associated with drug development. Its intended customers are pharmaceutical and drug development companies seeking earlier-stage compound screening. Further specifics on named products, customer wins, pricing, or documented technical moat are not known to me.